---
figid: PMC11041045__gr4
pmcid: PMC11041045
image_filename: gr4.jpg
figure_link: /pmc/articles/PMC11041045/figure/fig4/
number: Fig. 4
figure_title: ''
caption: 'Metabolic pathway analysis of identified potential metabolites. (A) Overview
  of metabolic pathway analysis in the Model (M) and Control (C) groups:1) Asthma.
  2) Toxoplasmosis. 3) Synthesis and degradation of ketone bodies. 4) Oxidative phosphorylation.
  5) D-Arginine and D-ornithine metabolism. 6) Aldosterone-regulated sodium reabsorption.
  7) Butanoate metabolism. 8) Mineral absorption. 9) Arachidonic acid metabolism.
  10) Lysine degradation. (B) Overview of metabolic pathway analysis in the QFM and
  Model (M) groups: 1) Basal cell carcinoma. 2) mTOR signaling pathway. 3) D-Arginine
  and D-ornithine metabolism. 4) Glutathione metabolism. 5) Linoleic acid metabolism.
  6) Cholesterol metabolism. 7) PPAR signaling pathway. 8) Ascorbate and aldarate
  metabolism. 9) Cysteine and methionine metabolism. 10) Arachidonic acid metabolism.
  (C) Relative abundance of the derivatives of short-chain fatty acids (SCFA). *P < 0.05,
  **P < 0.01.'
article_title: Qingfei mixture modulates the immune responses in lung cancer through
  modulating mTOR signaling and gut microbiota-derived short-chain fatty acids.
citation: Xiang Qian, et al. Heliyon. 2024 Apr 30;10(8):e29404.
year: '2024'

doi: 10.1016/j.heliyon.2024.e29404
journal_title: Heliyon
journal_nlm_ta: Heliyon
publisher_name: Elsevier

keywords:
- Qingfei mixture
- Metabonomics
- SCFAs
- Gut microbiota
- Lung cancer

---
